Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of HRS-1301 tablets in adult hypercholesterolemia and mixed dyslipidemia
CTR20254043Phase 2Active
- Sponsor
- Shandong Sende
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-1301 in hypercholesterolemia, combined dyslipidaemia, hyperlipidemia, sponsored by Shandong Sende. Started Nov 2025; status: active.
02
Drugs
HRS-1301
03
Conditions
hypercholesterolemiacombined dyslipidaemiahyperlipidemia
Beyond the preview
Go deeper on CTR20254043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254043.